A Study Of Patient-Derived Brain Tumor Models From Surgically Resected Brain Tumors

Overview

About this study

The purpose of this study is to generate patient-derived organoids, GSC cultures, and other experimental models using excess surgically resected brain tumor tissue.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adults 18 years of age or older undergoing clinically indicated surgical resection of primary glioblastoma and/or metastatic brain tumors.

Exclusion Criteria:

Individuals younger than 18 years of age; pregnant women; prisoners; and adults lacking capacity to provide informed consent. Fetuses and neonates will not be enrolled.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/17/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator	Contact us for the latest status

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials